Effects of (-)-epigallocatechin gallate on HMGB1 and interleukin-1β-mediated barrier disruption in human endothelial cells

Activated protein C inhibits high mobility group box 1 signaling in endothelial cells

(2011) J.-S. Bae et al.   BLOOD

Barrier protective effects of lycopene in human endothelial cells

(2011) Jae Woan Bae et al.   INFLAMMATION RESEARCH

Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells

(2010) Tae Hoon Kim et al.   FOOD AND CHEMICAL TOXICOLOGY

Epigallocatechin gallate–mediated protection against tumor necrosis factor-α–induced monocyte chemoattractant protein–1 expression is heme oxygenase–1 dependent

(2010) Yuanyuan Zheng et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption

(2010) Rachel K. Wolfson et al.   MICROVASCULAR RESEARCH

Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway

(2010) Jun Yang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Targeting HMGB1 in inflammation

(2009) Huan Yang et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Epigallocatechin-3-O-gallate Decreases Tumor Necrosis Factor-α–induced Fractalkine Expression in Endothelial Cells by Suppressing NF-ĸB

(2009) Ae Sin Lee et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Epigallocatechin gallate inhibits endothelial exocytosis

(2008) Munekazu Yamakuchi et al.   BIOLOGICAL CHEMISTRY

Vascular permeability in cardiovascular disease and cancer

(2008) Sara M Weis   CURRENT OPINION IN HEMATOLOGY